| Authors | Wei Liu, Hai-Liang Zhu, Yongtao Duan |
| Journal | Drug discovery today
(Drug Discov Today)
Vol. 25
Issue 12
Pg. 2071-2073
(12 2020)
ISSN: 1878-5832 [Electronic] England |
| PMID | 33035666
(Publication Type: Editorial, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Anti-Inflammatory Agents
- Antiviral Agents
- Spike Glycoprotein, Coronavirus
- spike protein, SARS-CoV-2
- Coronavirus RNA-Dependent RNA Polymerase
- ACE2 protein, human
- Angiotensin-Converting Enzyme 2
- Serine Endopeptidases
- TMPRSS2 protein, human
- FURIN protein, human
- Furin
- Coronavirus Papain-Like Proteases
- Coronavirus 3C Proteases
|
| Topics |
- Angiotensin-Converting Enzyme 2
- Anti-Inflammatory Agents
(therapeutic use)
- Antiviral Agents
(therapeutic use)
- COVID-19
(immunology, metabolism, therapy)
- Coronavirus 3C Proteases
(antagonists & inhibitors)
- Coronavirus Papain-Like Proteases
(antagonists & inhibitors)
- Coronavirus RNA-Dependent RNA Polymerase
(antagonists & inhibitors)
- Drug Development
- Furin
(antagonists & inhibitors)
- Host Microbial Interactions
(genetics, immunology)
- Humans
- Immunity, Innate
- Immunization, Passive
- Molecular Targeted Therapy
- SARS-CoV-2
(genetics, immunology, metabolism)
- Serine Endopeptidases
- Spike Glycoprotein, Coronavirus
- COVID-19 Drug Treatment
- COVID-19 Serotherapy
|
